Impressive revenue growth but I want to see cash receipts to assess churn level. Also want to see the cash burn to assess how much this revenue growth is costing. 4c will be interesting reading.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025